The vascular endothelial growth factor (VEGF) family binds multiple endothelial cell surface receptors. Our goal is to build comprehensive models of these interactions for the purpose of simulating angiogenesis. In view of low concentrations of growth factors in vivo and in vitro, stochastic modeling of molecular interactions may be necessary. Here, we compare Monte Carlo simulations of the stochastic binding of VEGF and two of its major receptors on cells in vitro to equivalent deterministic simulations. In the range of typical VEGF concentrations, the stochastic and deterministic models are in agreement. However, we observe significant variability in receptor binding, which may be linked to biological stochastic events, e.g., blood vessel sprout initiation. We study patches of cell surface of varying sizes to investigate spatial integration of the signal by the cell, which impacts directly the variability of binding, and find significant variability up to the single-cell level. Dimerization of VEGF receptors does not significantly alter the variability in ligand binding. A Fsliding window_ approach demonstrated no reduction in the variability of binding by temporal integration. The variability is expected to be more prominent in in vivo situations where the number of ligand molecules available for binding is less. D
Introduction
Angiogenesis (neovascularization) is a vital process for physiological growth, development and wound healing, as well as for pathologies such as cancer and diabetic retinopathy. Many biological molecules are involved in the regulation of angiogenesis including multiple growth factor families, matrix metalloproteinases, heparan sulfate proteoglycans, integrins, and endothelial cell-surface receptor tyrosine kinases. Parenchymal cells, in response to low oxygen or other stressors, release cytokines such as vascular endothelial growth factor (VEGF). These glycoproteins diffuse through the interstitial space to endothelial cells that form capillaries, where they bind to and activate receptors on the endothelial cells. This can lead to extracellular matrix proteolysis, endothelial cell migration, proliferation and formation of new capillary networks. In vitro, these growth factors have significant impact on cultured endothelial cells, increasing survival, migration and proliferation.
Computational models have been used to study different aspects of the angiogenic process. One kinetic model describes the competitive binding between VEGF and placental growth factor in in vitro assays [1] ; another includes VEGF isoforms and their interactions with VEGF receptor 2 and neuropilin-1 [2] . Concentrations of VEGF used in such assays typically range from 10 pM to 10 nM. Physiological concentrations of many molecules involved in angiogenesis are in the picomolar range; in one study, VEGF protein concentration in rat organs ranged from 22 pM (spleen) to 21 nM (omentum), with 140 pM and 760 pM in heart and skeletal muscle, respectively [3] . Mean VEGF concentrations (measured across many patients) of 2 -7 pM were found in the avascular spinal cord [4] . Blood VEGF is also low; in plasma, 1 -10 pM [5, 6] ; in serum, 3-5 pM [7] . These are means; individuals may have even lower concentrations. Sub-nanomolar concentrations equate to less than one ligand molecule in each cubic micron of fluid. In view of these low concentrations, there are two fundamental questions to be asked. First, are the predictions of a deterministic model based on the continuum approximation valid at low ligand concentrations? The continuum approach assumes that the density of molecules is large enough to be represented by a concentration rather than tracking individual molecules. A failure of the continuum approximation would be observed as a divergence of the mean of many stochastic 0167 predictions and the deterministic prediction. Second, what is the variability of receptor-ligand binding around the mean? The deterministic model describes the average behavior of the system; however, at low concentrations, the variance of ligand -receptor interactions in such an environment could be very significant. This variance could result in localized responses to growth factors, if the response is based on a threshold function [8] . For example, with low variance, all cells (or all areas of a cell) exposed to the same VEGF concentration will have an equivalent number of ligand -receptor complexes formed; if the variance is high, cells will demonstrate varying levels of complex formation, and thus varying levels of signaling. If the cell only responds (e.g., proliferates or migrates) when the signal reaches a threshold level, some cells will respond and not others; whereas, with low variability, all cells will respond identically.
Stochastic approaches have been used to study similar systems and non-system-specific ligand -receptor interactions. In systems with extremely low (attomolar) ligand concentrations, the coefficient of variation was found to be highly dependent on the reaction scheme, and could be used to discriminate between cooperative and non-cooperative models of ligand-receptor interaction [9] . In that model, analytical equations were derived for the binding probabilities, but that approach could not be used to produce results for our scenario, as it requires that ligand be in excess over receptor, which is not always the case here. Deriving analytical probabilistic equations that incorporated association and dissociation binding rate constants and multiple receptor types would be a significant challenge. Other stochastic models describe autocrine and paracrine ligand trapping distance from the point of secretion for epithelial layers and cell cultures [10, 11] , however, analytical expressions for the binding of ligands to the receptors are not available. In order to study the variance of VEGF ligand -receptor interactions under different in vitro conditions, we have employed two Monte Carlo simulation approaches. The first uses the MCell software [12] (http:// www.mcell.cnl.salk.edu). With MCell, the VEGF molecules move in a three-dimensional space and bind to receptors that are immobilized on a two-dimensional surface; thus this is similar to simulating in vitro experiments with a partial differential equation. The second uses the Gillespie algorithm [13] . This method includes the kinetics of ligand-receptor binding but does not include the diffusion of molecules and thus is similar to an ordinary differential equation description. The extension of this analysis to an in vivo situation is not part of this study. This is the first study to compare the deterministic and stochastic results for a kinetic model of binding of this growth factor-receptor family.
In all the simulations, we have focused on one common isoform of VEGF (VEGF 165 ) and two of its receptors, VEGFR1 (Flt-1) and VEGFR2 (KDR/Flk-1) (for reviews, see refs. [14 -16] ). A range of ligand concentrations was studied, and the ratio of the two receptors was varied. Results of stochastic simulations are compared with the results of deterministic simulations performed using the full kinetic method described previously [1] that takes into account the gradients of ligands in the medium above the cell monolayer. If the cell integrates the signal coming from multiple receptors in a local area, the stochastic properties of the signal would depend on the area of interest. To compare the simulations, we used fractional occupancy of each receptor type (VEGFR1 or VEGFR2) in that area of cell membrane as a measure of binding, comparing the prediction of the deterministic simulation with the mean of many runs of the stochastic simulation. For the deterministic model, the size of the membrane does not affect the result; however, the size of this area will determine the number of receptors the cell is integrating, and thus the variability of the integrated signal. We calculated the coefficient of variation for the stochastic simulation as a measure of the variability in the binding.
Methods

Deterministic model
The deterministic, kinetic model was based on the models of in vitro experiments developed previously [1, 2] . In brief, the receptors are assumed to be uniformly distributed over the surface of the cell, and the ligand concentration is assumed to be uniform in the planes parallel to the surface, varying only in the direction normal to the endothelial monolayer. Gradients are allowed to develop in this direction. Ligands diffuse through the medium and bind to receptors forming ligand -receptor complexes. Ligands can be released from these receptors, or they may be internalized. In these simulations of in vitro cell cultures at 4 -C, it is assumed that no internalization takes place. The resulting coupled set of partial differential equations was non-dimensionalized; a fully implicit finite-difference scheme was applied, and implemented on a PC.
3D stochastic software
MCell (http://www.mcell.cnl.salk.edu), a general Monte Carlo simulator of cellular microphysiology was used for three-dimensional stochastic simulations. Programming was done using a custom Model Description Language (MDL) built into MCell. UNIX shell scripting and FORTRAN coding were used for simulation automation and data analysis, respectively.
Simulated environment
In in vitro experiments, a monolayer of endothelial cells is covered by a layer of fluid medium approximately 1000 Am thick. Ligands are initially uniformly dispersed within this fluid. Endothelial cells have approximately 1000 Am 2 of ''lumenal'' surface area [1] . For the simulations, cell surface sections of 1 Am Â 1 Am and 2 Am Â 2 Am were selected. Thus the dimensions of the simulation environments were 1 Am Â 1 Am Â 1000 Am and 2 Am Â 2 Am Â 1000 Am.
An endothelial cell typically has 1 -100 VEGFR1 or VEGFR2 receptors/ Am 2 [17 -20] . For the simulations, these two receptors were placed in different ratios on the cell surface sections. MCell uses a barycentric subdivision method to divide the cell surface section into an equal number of triangular effector tiles. For all simulations, an effector tile density of 10 4 tiles/Am 2 was specified. Thus, each triangular effector tile had a surface area of 100 nm 2 . Desired VEGFR1 and VEGFR2 receptor densities are specified (5, 25 or 125 per Am 2 ), and a random number generator determines whether or not a particular effector tile should be labeled as a receptor. Each Monte Carlo run uses a different seed value to generate a new random number stream, resulting in variability in the number of receptors produced. This variability is accounted for in interpreting the results (see Results) . Seed values which result in zero receptors were discarded.
Three ligand concentrations were used for VEGF 165 : 20 pM, 200 pM and 2 nM. These molar concentrations equate to approximately 13, 120 and 1250 total ligands in the 1 Am Â 1 Am Â 1000 Am fluid column. For these three ligand quantities, the ligands were released in equal packets at 13, 12 and 10 equally spaced points along the vertical axis of the fluid column. In the 2 Am Â 2 Am Â 1000 Am fluid column, the same initial placement of ligands was used, but with four 1 Am Â 1 Am Â 1000 Am fluid columns placed adjacent to each other (ligands move freely between columns). The purpose of the initial placement of ligands in a grid-like pattern is to provide a pseudo-uniform concentration. The ligands were allowed time to equilibrate before binding could begin.
Simulation execution
Simulations were executed for different elapsed times depending on the ligand concentration. Systems with lower ligand concentrations took longer to reach steady state. After the initial ligand placement, the simulation is executed for 200 s (10 6 iterations), with all binding probabilities set to zero. During this mixing period, the ligands diffuse without interacting with the cell surface. Systematic non-uniformity from the initial placement of ligands is practically eliminated by this mixing step. Binding probabilities are then set to their control values and each simulation is run for a specified time. Simulations for different sets of parameters (ligand concentrations, surface areas, receptor densities) are executed for at least 30 and up to 100 different values of the random number seed to ensure representative sampling; the actual number of runs for each simulation is noted in the figure in which the results of that simulation first appear.
Gillespie algorithm
To compare the results of the three-dimensional MCell simulation to a simpler compartmental model, we used the Gillespie algorithm [13] . The total numbers of VEGF (#V), VEGF receptor (#R), and VEGF-VEGF receptor complexes (#VR) are tracked and the reaction rates are represented as
where the on rate is normalized by the volume (Vol) and Avogadro's number (N A ), and
Two random numbers, p 1 and p 2 , are generated. The time until the next reaction is
and the reactions take place as:
The numbers of molecules and reaction probabilities are then updated for the next step. Monte Carlo implementation of the algorithm was written in FORTRAN.
Model parameters
The same parameters are used in both the deterministic and stochastic models. The fluid solution above the cell monolayer was assumed to be aqueous. Thus, an aqueous diffusion coefficient D L of 2.0 Â 10 À6 cm 2 /s was used for deterministic and MCell simulations, based on the molecular weight of VEGF [21] . The kinetics of VEGF binding to its receptors was obtained from the literature; for VEGF 165 and VEGFR1, k on and k off parameters were found to be 4 Â 10 6 M À1 s À1 and 3 Â 10 À5 s À1 , respectively, for a binding affinity of 7.5
pM [22] . The k on and k off values for VEGF 165 and VEGFR2 were measured as 3.6 Â 10 6 M À1 s À1 and 1.34 Â 10 À4 s
À1
, respectively, for a binding affinity of 37 pM [23] . A time step of 2 Â 10 À4 s per iteration was used for MCell simulations. The time step is variable (randomly generated) in the Gillespie algorithm.
Data extraction and analysis methods
The raw data produced by the stochastic simulations is in the form of the number of each species (i.e. free ligand, free receptor, bound receptor) present at each timepoint. FORTRAN programs are used to sort data from different runs and compute the variables of interest-the mean fractional occupancy, and the coefficient of variation (CV = j/l, where r is the standard deviation and l is the mean). The mean and variation over time are plotted, with particular focus on the values of these variables at steady state and at 5 -10 min post-VEGF addition. This latter condition represents the time at which peak phosphorylation of VEGF receptors is typically observed.
Results
One receptor: VEGFR2
VEGFR2 is the main signaling receptor for VEGF on endothelial cells; phosphorylation of VEGFR1 is not as strong. We examine first the binding of VEGF to this receptor expressed alone on endothelial cells in vitro. This represents a realistic experimental situation, e.g., the expression of VEGFR2 on porcine aortic endothelial cells, which do not have other VEGF receptors. For a 1 Am 2 patch of cell membrane, containing on average 25 receptors (equivalent to 25,000 receptors/cell), the mean of the stochastic results for the fractional occupancy of VEGFR2 fit well to the deterministic results at 200 pM initial VEGF concentration (Fig. 1A) . However, at lower initial VEGF concentrations, e.g., 20 pM, there is a deviation between the stochastic result and the deterministic prediction. This discrepancy is not decreased by increasing the number of runs of the MCell software (100 runs are used in Fig. 1A ), but is alleviated by running the stochastic simulation for a 4 Am 2 patch of membrane (Fig. 1C) , suggesting that the problem may be related not to the concentration, but to the total number of ligands involved in the simulation. The number of free ligands available for binding at steady state is predicted to be 98 for 200 pM, but only 7 for 20 pM in the 1 Am 2 configuration, rising to 28 for the 4 Am 2 area. For the smaller number of ligands, the large volume (1000 Am 3 ) means that most of these ligands will not be close to the surface, resulting in a very small ligand number available for binding, possibly less than one on average. This would be a source of discrepancy between the deterministic and stochastic models, as the stochastic model will have either zero or one ligands present, with very different outcomes for each; the deterministic model allows concentrations between zero and one molecules which deals smoothly (though possibly inaccurately) with the situation.
At higher concentrations, e.g., 2 nM, the stochastic simulation appears to deviate again for a 1 Am 2 patch (Fig.  1A) , but now the deterministic result underestimates the true binding to the receptors. The stochastic results at 4 Am 2 agree with the deterministic (Fig. 1C) . The number of ligands should be sufficient to approximate the binding, so this suggests that the number of receptors may also be important. Since the number of receptors is the same at all concentrations, the number of free receptors which are available for binding is likely to be affecting the result. For 20 pM, the average density of free (unbound) receptors at steady state is 20 Am À2 ; at 200 pM, 4.8 Am À2 ; at 2 nM, 0.5 Am À2 . For 4 Am 2 , the total number of free receptors is four times larger, bringing the 2 nM simulation out of the problem of having less than one free receptor on average. The same argument as for ligand concentration above applies to these small concentrations and the ways they are dealt with by the deterministic and stochastic models. Note that at intermediate concentrations, agreement is seen at both patch sizes.
However, the 1 Am 2 patch of membrane should not exist in isolation. Therefore, we simulated a 4 Am 2 patch, but tracked the receptors in one 1 Am 2 area to check if the discrepancy persists. In this case, for both 20 pM and 2 nM VEGF, we observe no significant deviation from the deterministic solution (Fig. 1E, G) . This suggests that the disagreement observed earlier is an artifact of the small simulation volume. It remains an open question whether significant clustering-VEGF receptors surrounded by empty membrane area-would affect the results.
The variance of the stochastic results was used to calculate the coefficient of variation of the fractional occupancy (Fig.  1B, D) . The variation in the binding to receptors can have a meaningful effect where signaling and downstream responses are based on a threshold level of activation [8] . Shortly after growth factor addition, as binding begins, the variance is very high, but it falls as binding equilibrates to a steady state level, which depends on VEGF concentration but is significant at all concentrations shown. The coefficient of variation decreases as the membrane patch size increases, but remains high for the case of the 1 Am 2 patch within a larger simulation area (Fig. 1F, H) , suggesting that the variability is not an artifact of the discrepancies observed in small simulation volumes, and may be significant over a larger surface area than shown here.
The steady state and short time fractional occupancies calculated from the deterministic model are shown to be close approximations for the mean occupancies in the Monte Carlo model ( Fig. 2A and C) . The coefficient of variation decreases with increasing VEGF concentration, and with increasing membrane patch size (Fig. 2B and D) .
To investigate the effect of receptor number on the variance, the simulation was run for 200 pM VEGF binding to a 1 Am 2 patch of 5, 25 or 125 receptors (representing cells with 5000, 25,000 and 125,000 receptors). The deterministic model predicts a decrease in fractional occupancy as the receptor concentration increases (Fig. 3A) . The stochastic model agrees well at 25 and 125 receptors/Am 2 , but not for 5 receptors/Am 2 . The number of unbound VEGF molecules is 39, 98 and 115, which in line with earlier results should be sufficient for agreement. The number of unbound receptors at steady state is predicted to be approximately 25, 5 and 0.9 per Am 2 for 125, 25 and 5 receptors/Am 2 , respectively. This small free receptor number leads to the discrepancy between the deterministic and stochastic models. 5000 receptors/cell would demonstrate 3.6 free receptors in a 4 Am 2 membrane, allowing that simulation to converge to the deterministic prediction (data not shown). The coefficient of variation in the fractional occupancy decreases with increasing receptor number (Fig. 3B) .
Variation in receptor number does not account for the variability in binding
The allocation of the receptors by the MCell program introduces variability into the results; this is why we used the fractional occupancy. The fractional occupancy should be less susceptible to the receptor number variations than the ligand -receptor complex number. For the 1 Am 2 simulations, the coefficient of variation of the receptor number was 18%; for 4 Am 2 , 10%. However, the effect on fractional occupancy of this variation in receptor number is progressively smaller as the number of ligands added initially becomes greater; for 20 pM, the fractional occupancy would show a coefficient of variation of 7.5% (or 4.1% for 4 Am 2 ); 200 pM, 0.7%; 2 nM, less than 0.01%. For each concentration, we note that the observed coefficient of variation is at all times larger than these predictions (Fig. 1B, D, F, H) , and the remainder is assumed to be non-receptor numberrelated variance.
Gillespie algorithm: one receptor
To verify the results of the MCell software, we used a second method to stochastically simulate the ligand -receptor binding, without including the three-dimensional motion of VEGF molecules. Using this algorithm, the mean fractional occupancy for 1 Am 2 ( Fig. 4A ) and 4 Am 2 ( Fig. 4C) are the same and agree with the deterministic results. The coefficient of variation (Fig. 4B, D) is in close agreement with that predicted by MCell simulations (Fig. 1B, D) with the exception , where the Gillespie algorithm predicts lower variability than MCell; this is likely due to the availability of all VEGF to bind receptors in the Gillespie algorithm, where VEGF molecules may be distant from the surface in the MCell simulations. When the 1 Am the variability found was the same as that predicted by the Gillespie algorithm for 1 Am 2 . Using the Gillespie algorithm, we then investigated the impact of membrane area on the coefficient of variation of the fractional occupancy (Fig. 4E, F) . Even over a large surface area equivalent to a full endothelial cell (¨1000 Am 2 ) the variability in binding at the time of peak phosphorylation (5 -10 min) is greater than 1% for VEGF concentrations below 200 pM. While tracking a subset of receptors equivalent to a 1 Am 2 patch of membrane, we increased the total number of receptors but found no change in the variability in binding in the small patch ( Fig. 4G -H) , explaining the agreement between the 1 Am 2 in 4 Am 2 MCell results and the 1 Am 2 Gillespie results. This suggests that signal integration at the local level just within the membrane will demonstrate considerable variability: 5% to 50% at steady state (10% to 150% at 5 -10 min) for initial VEGF concentrations less than 1 nM.
Two receptors: VEGFR1 and VEGFR2
We next simulate a cell with equal densities of VEGFR1 and VEGFR2. These two receptors have differing kinetics for VEGF, VEGFR1 having greater affinity than VEGFR2. For a 1 Am 2 patch of membrane (data not shown), the deterministic and MCell stochastic models agree well at 200 pM VEGF. However, as before, at 20 pM significant deviation from the predicted occupancies of both receptors is observed. This deviation vanishes when the simulations are run for a 4 Am 2 area (Fig.  5A) . The variability again decreases with increasing VEGF concentration (Fig. 5B) . The variability in fractional occupancy of VEGFR2 is consistently higher than that of VEGFR1, presumably reflecting the decreased affinity for VEGFR2 relative to VEGFR1. Note also that the mean fractional occupancy of VEGFR2 and its coefficient of variation are both slightly reduced by the presence of VEGFR1 (compare Fig. 5A -B to Fig. 1C -D) . The variability in binding to the receptors is higher at earlier times (Fig. 5E -F) . At 2 nM, there is a discrepancy between the deterministic and MCell stochastic results for a 1 Am 2 membrane patch, though less in this case than for a single receptor due to a higher total concentration of receptors. The Gillespie algorithm again reproduces the results of the MCell simulation at 4 Am 2 (Fig. 5C, D) . The receptors for VEGF are not typically present in equimolar quantities on the endothelial cell surface, however. We simulated a cell with 5000 VEGFR1 receptors and 25,000 VEGFR2s. For a 1 Am 2 patch of membrane, we again see significant deviation from the deterministic model predictions for the stochastic results at low VEGF concentrations (data not shown), and these differences again disappear for a 4 Am 2 membrane area (Fig. 6A) . We see variabilities in excess of those predicted by receptor variation (Fig. 6B) , and the variability of VEGFR1 is now higher than that of VEGFR2. Predictions of the Gillespie algorithm for 4 Am 2 (Fig. 6C, D ) match the results of the MCell simulation. To further test our hypothesis that the discrepancies between the MCell stochastic and deterministic results can be ligand -number dependent, we noted that for 20 pM, the 1 Am 2 patch had divergent stochastic and deterministic results, while the 4 Am 2 patch results agreed. The mean numbers of free ligands for these situations at steady state were 7 and 21, respectively. We then constructed simulations which would result in 7 free ligands for the 4 Am 2 patch, and 21 for the 1 Am 2 patch (6 pM and 57 pM, respectively). The higher concentration 1 Am 2 patch agreed with the deterministic results; the lower concentration 4 Am 2 patch now diverged. We conclude that free ligand number is important to the consistency of deterministic and MCell stochastic results, just as free receptor number was shown to be earlier. The steady state and short-time variance at these concentrations is in line with the predictions for other concentrations (Fig. 6E -F) .
Dimerization of VEGF receptors
VEGF is a dimeric protein with two binding sites for receptor monomers, one at each pole of the protein. The mechanism of dimerization is not known, but it is possible that the mechanism affects the variability in signaling. We compare the 1:1 ligand -receptor binding model to several possible mechanisms of dimerization: SPD, static pre-dimerization (ligand binds two predimerized receptor monomers); DPD, dynamic pre-dimerization (receptors dimerize and dissociate independent of ligand); and LID, ligand-induced dimerization (ligand binds receptor monomer, then binds second monomer) [24] . We applied the Gillespie algorithm and found that the average fractional occupancy for each mechanism matches the deterministic model (Fig. 7A, B) and that the variability in the binding is similar for each dimerization mechanism, and similar to the simple 1:1 binding model (Fig. 7C) . Only ligand-induced dimerization of non-associating receptor monomers demonstrated a slightly lower variability.
Single-receptor bound probability and variability
With the fractional occupancy and coefficient of variation of an ensemble of receptors (5 or 25 for 1 Am 2 , 20 or 100 for 4
Am 2 ) known, what is the probability of any one receptor being bound at a point in time, and what is the variance associated with that? Assuming each receptor has the same probability p of being bound to a ligand, the variance associated with this is pI(1Àp) as each receptor can only be in one of two states, bound or unbound. For n total receptors the expected value of the number of bound receptors is l = nI p, and that of the fractional occupancy is l u = l/n = p. The variance of the number of bound receptors is r 2 = nIpI(1Àp), and the variance in the fractional occupancy is thus r u 2 = ( p I(1Àp))/n. Note that the fractional occupancy and the bound probability are identical; the variance decreases with 1/n, so that the coefficient of variation for a single receptor can be related to the observed coefficient for n receptors as CV 1 ¼ ffiffi ffi n p ICV n . This analysis assumes each receptor acts independently. The single-receptor coefficient of variation for Gillespie algorithm simulation of many ligand-receptor concentration combinations is shown in Fig. 8, along with the results of several MCell simulations. Note that the steady-state variability is almost independent of receptor concentration (and area of interestnot shown). Thus, the overall coefficient of variability varies approximately with the square root of receptor density. We would expect the variability to increase at higher receptor densities, as the cell sequestered more of the ligand and the fractional occupancy of the receptors decreased, but this is not observed: calculating the variability of binding from the free ligand concentration, rather than directly from the results, leads to an overestimation of the variation (lines, Fig. 8A ). On the other hand, calculation of variability based on free ligand concentration at early times significantly underestimates the variation (Fig. 8B) . Note that this is not the same as the result that would be obtained by exposing a single receptor to ligand; the variability (and the occupancy probability) includes the information of the density of receptors around the receptor of interest. Because of this, such a single-receptor simulation could not be interpreted to find the variability of the fractional occupancy of a receptor ensemble.
Temporal integration
Cells may attempt to smooth the variations in receptor binding by integrating over space as described earlier. Another strategy would be to integrate the signal over time. To mimic the consequences of this, we applied a Fsliding window_ averaging to the results of each run of the stochastic model. The new data were then compiled to find the mean fractional occupancy and the coefficient of variation of the timeintegrated data. For a window of 1 h, the mean fractional occupancy, as expected, followed the trend of the unintegrated results, though smoothed and with a time lag (Fig. 9A) . Windows of 6 s, 60 s and 600 s yielded results that were indistinguishable from the original results at this scale (data not shown). Despite the smoothing of the curve, the coefficient of variation for these time-integrated results was also relatively unchanged from the original results (Fig. 9B) , suggesting that the majority of the variation observed is between runs of the simulation rather than between timepoints in the same run. Shorter time windows were not significantly different from the original. Temporal integration was performed on other single and double receptor simulation results and similar results were found.
Discussion
We have investigated the behavior of VEGF -VEGF receptor binding to endothelial cells using deterministic and stochastic methods, looking in particular at the area over which the cell is Fintegrating_ the signals from its activated receptors. Cells cannot respond independently to each ligand -receptor binding event; with a population of several thousand receptors, the cell must integrate the signal at some point in signal transduction. The extent of the integration may depend on the signal pathway, for example, proliferation may be the result of integrating cues from the entire cell surface, whereas chemotactic or haptotactic migration may require the comparison of signals from different parts of the same cell, and the integration would thus be over a smaller area. We also note that the receptors on cells tend to cluster rather than be distributed throughout the plasma membrane. Clusters of VEGFR2 observed on endothelial cells in vitro were of 4 -6 Am 2 area, and covered 20% of the cell surface area [25] , implying a fivefold concentrating of receptors.
The continuum approximation is useful for the study of molecular interactions when the species in question are not present in extremely small quantities and individual molecules can be represented instead as concentrations. VEGF binds to several receptors on the surface of endothelial cells, and our goal in this study was to compare deterministic models built using the continuum approximation to stochastic models where all molecules are explicitly represented. We tracked the fractional occupancy of the VEGF receptors over time in response to VEGF addition to the medium above a monolayer of cells. We used two Monte Carlo methods, one which tracks individual molecules in 3D space and one which does not. For the first model type (using MCell software), we found that the agreement between the stochastic and deterministic results depended upon the area over which the fractional occupancy is averaged, which is equivalent to the area over which the cell is integrating the signals from its activated receptors. However when considered as part of a larger area, discrepancies between the models disappeared at typical ligand concentrations and receptor densities. For the second stochastic model type (employing the Gillespie algorithm), results agree with the deterministic models over all areas, ligand and receptor densities tested. We conclude that the deterministic models are suitable for simulating in vitro experiments of VEGF -VEGF receptor system on endothelial cells.
As well as the agreement of fractional occupancy predictions of stochastic and deterministic models, we also measured the variability of binding using the stochastic models. The variability, as measured by the coefficient of variation, was shown to be highly dependent on ligand and receptor concentrations (Fig. 10) . It was also higher at early times, which has implications for periods of peak phosphorylation, but could also hold a significant steady state value. Variability was not reduced by introducing temporal integration of the binding, nor by the inclusion of any of several mechanisms of receptor dimerization. Increasing the area of integrationwhich, like increasing receptor density, increases the total number of receptors being integrated-does reduce variability; however any size subpatch within that area will have higher variability than the patch as a whole. The two stochastic model types used here show agreement in the predicted variability of binding. This agreement indicates that the VEGF gradients are not significant enough in the cases studied here to cause significant differences between the 3D and non-dimensional models. Gradients would be increased by more receptors, faster binding kinetics and/or slower ligand diffusion.
This demonstration of significant VEGF receptor binding variability in vitro is for experiments at 4 -C, with no receptor internalization or ligand secretion. While many experiments are performed under these conditions, the analysis should be repeated for room-temperature and body-temperature experi- ments, including both of these cell-surface processes. Gradients of VEGF are expected to be greater than observed here, requiring the use of three-dimensional MCell simulations rather than the non-dimensional Gillespie method. The comparison should also be extended to the in vivo situation. The volume available for ligand transport in vivo (extracellular space) per surface area of endothelial cell is smaller than in vitro, thus the number of molecules available at a given concentration is also smaller. These scales mean that it is more likely in the in vivo case that the continuum approximation may fail, and the variability in VEGF -VEGFR binding will be even higher. Such an extension should also take into account secretion of VEGF from one cell type and binding to another, without the bolus of initial VEGF seen in in vitro experiments. In addition, the extracellular matrix affects the movement of growth factors, both as a physical barrier to diffusion, and as a reservoir for ligand binding.
